4 ms·
Incentives in medical research are screwed. This article just scratches the surface. In general, doing research towards direction that might lead to molecule
by nabla9 6y ago
Incentives in medical research are screwed. This article just scratches the surface.
In general, doing research towards direction that might lead to molecule that can't be patented is not possible in commercial medical research. Research is actively directed away from cheap treatments or drugs.
- bad_user 6y agoResearch is super expensive, and the low hanging fruits have been picked. There's no such thing as a cheap drug, unless that cost is subsidized. Also consider that the lifetime for drugs against viruses or other pathogens can be fairly short. Viruses that are a problem now, like SARS-Cov-2, might be a non-issue 3 years from now, or the vaccines we develop now might be ineffective against future strains. Unless the government or non-profit organizations can promise grant money, in exchange for R&D, then patents are reasonable. And note that 20 years is a very long time in IT, but not in Pharma. Many drugs developed 20+ years ago are just as good today.
- nabla9 6y ago> and the low hanging fruits have been picked Only the low hanging fruits that can be patented have been picket. Cheap paths are blocked by incentives. Between the size of typical government funding and patentable drug there is huge gap of few hundred millions. > There's no such thing as a cheap drug Existing molecular entities where the patent has expired are cheap. Besides, the it does not have to be new drug. Effective treatment can be something else.
- natechols 6y agoThere is a lot of nonsense tossed around about who actually discovers the majority of drugs and how the public sector can be more involved, but you've identified one case where government and academia could make a huge difference, e.g. by running clinical trials on off-patent drugs applied to new conditions. Low risk, low cost, and very little incentive for big pharma, but a big win for taxpayers if the trials identify cheap new cures.
- HeadsUpHigh 6y agoClinical trials are never low cost. Even small scale studies with a few subjects can climb in eye-watering numbers.
- Cpoll 6y agoWhy? Not that I don't believe you, but I can't get a back-of-the-envelope estimate to go that high (certainly from lack of knowledge on my part). But I'm picturing the kind of study you see in posters on mass transit: "Are you X, Y, and Z and suffering from W? You might be eligible for experimental treatment. Call this number."
- HeadsUpHigh 6y agoI remember a recent study on a new supplement that costed ~10k per subject for a 6 month trial. There's a lot of hidden cost wrt bureaucracy and other such issues.
- nabla9 6y agoThere is this joke about a guy who goes to patent office and says "I invented dynamite!". Patent clerk says: "But dynamite has already been invented." Guy: "I invented more of it." Drug development is like that. Huge sums of money is spent for creating slightly different molecules to create competitor for already existing drug. When someone discovers way to treat disease with drug. Competitors learn how the drug works and develop another molecule with similar function that circumvents patents. That money should be used to original drug research that is more risky and uncertain but it generates less profits.
- natechols 6y ago"Lower cost", I should have said. Skipping straight to Phase III helps.
- raxxorrax 6y agoLooking at prices for general medicine in the US lets me suggest that even stronger regulation might be needed. Doesn't the government fund research grants with several billions each year?